Literature DB >> 9222102

A t-statistic for objective interpretation of comparative genomic hybridization (CGH) profiles.

D H Moore1, M Pallavicini, M L Cher, J W Gray.   

Abstract

An objective method for interpreting comparative genomic hybridization (CGH) is described and compared with current methods of interpretation. The method is based on a two-sample t-statistic in which composite test:reference and reference:reference CGH profiles are compared at each point along the genome to detect regions of significant differences. Composite profiles are created by combining CGH profiles measured from several metaphase chromosomes for each type of chromosome in the normal human karyotype. Composites for both test:reference and reference:reference CGH analyses are used to generate mean CGH profiles and information about the variance therein. The utility of the method is demonstrated through analysis of aneusomies and partial gain and loss of DNA sequence in a myeloid leukemia specimen. Banding analyses of this specimen indicated inv (3)(q21q26), del (5)(q2?q35), -7, +8 and add (17)(p11.2). The t-statistic analyses of CGH data indicated rev ish enh (8) and rev ish dim (5q31.1q33.1,7q11.23qter). The undetected gain on 17p was small and confined to a single band (17p11.2). Thus, the t-statistic is an objective and effective method for defining significant differences between test and reference CGH profiles.

Entities:  

Mesh:

Year:  1997        PMID: 9222102     DOI: 10.1002/(sici)1097-0320(19970701)28:3<183::aid-cyto1>3.0.co;2-f

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  8 in total

Review 1.  Comparative genomic hybridisation.

Authors:  M M Weiss; M A Hermsen; G A Meijer; N C van Grieken; J P Baak; E J Kuipers; P J van Diest
Journal:  Mol Pathol       Date:  1999-10

2.  Genetic imbalances with impact on survival in head and neck cancer patients.

Authors:  U Bockmühl; K Schlüns; I Küchler; S Petersen; I Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Chromosomal integrity of human preimplantation embryos at different days post fertilization.

Authors:  Michal Dekel-Naftali; Ayala Aviram-Goldring; Talia Litmanovitch; Jana Shamash; Hagith Yonath; Ariel Hourvitz; Yuval Yung; Masha Brengauz; Eyal Schiff; Shlomit Rienstein
Journal:  J Assist Reprod Genet       Date:  2013-04-18       Impact factor: 3.412

4.  Genomic instability in pituitary adenomas.

Authors:  Janusz Szymas; Karsten Schluens; Wlodzimierz Liebert; Iver Petersen
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

5.  Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas.

Authors:  Thomas Knösel; Youngwei Yu; Ulrike Stein; Holger Schwabe; Karsten Schlüns; Peter Michael Schlag; Manfred Dietel; Iver Petersen
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Single-cell chromosomal imbalances detection by array CGH.

Authors:  Cedric Le Caignec; Claudia Spits; Karen Sermon; Martine De Rycke; Bernard Thienpont; Sophie Debrock; Catherine Staessen; Yves Moreau; Jean-Pierre Fryns; Andre Van Steirteghem; Inge Liebaers; Joris R Vermeesch
Journal:  Nucleic Acids Res       Date:  2006-05-12       Impact factor: 16.971

7.  Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung.

Authors:  S Petersen; M Aninat-Meyer; K Schlüns; K Gellert; M Dietel; I Petersen
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Oligonucleotide arrays vs. metaphase-comparative genomic hybridisation and BAC arrays for single-cell analysis: first applications to preimplantation genetic diagnosis for Robertsonian translocation carriers.

Authors:  Laia Ramos; Javier del Rey; Gemma Daina; Manel García-Aragonés; Lluís Armengol; Alba Fernandez-Encinas; Mònica Parriego; Montserrat Boada; Olga Martinez-Passarell; Maria Rosa Martorell; Oriol Casagran; Jordi Benet; Joaquima Navarro
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.